NCT04874207 2025-08-08
RePERSO
Rennes University Hospital
Phase 4 Completed
Clinical Trials
28 trialsNCT03133273 2024-10-18
ONCOGRAM
University Hospital, Limoges
Phase NA Completed
NCT03164655 2024-10-01
SULTAN
UNICANCER
Phase 2 Completed
NCT03439462 2024-01-02
Nab-Sirolimus in Combination With FOLFOX & BEV as 1st Line Therapy in Patients With Advanced or Metastatic Colorectal Cancer
Aadi Bioscience, Inc.
Phase 1/2 Completed
NCT04721301 2023-10-17
Ipilimumab, Maraviroc and Nivolumab in Advanced Metastatic Colorectal and Pancreatic Cancer the LUMINESCENCE Trial
University Hospital Heidelberg
Phase 1 Completed
NCT06027775 2023-09-07
Chemotherapy Alone Versus Chemotherapy Plus Targeted Therapy as Adjuvant Therapy for Initially Unresectable Colorectal Cancer Liver Metastases
Fudan University
Completed
NCT05995990 2023-08-16
Raman Spectroscopy for Liver Tumours Following Liver Surgery
Nottingham University Hospitals NHS Trust
Phase NA Completed
NCT04790448 2023-02-15
Efficacy of VIC Regimen in BRAF Mutant Metastatic Colorectal Cancer
Sun Yat-sen University
Phase 1/2 Completed
NCT03750175 2023-02-03
OPTIPAL-II
Aarhus University Hospital
Completed
NCT03251612 2023-01-18
Predictive Value of Drug Sensitivity Testing Tumorspheres From Patients With Metastatic Colorectal Cancer
Vejle Hospital
Phase 2 Completed
NCT03007407 2022-12-05
Study of Durvalumab and Tremelimumab After Radiation for Microsatellite Stable Metastatic Colorectal Cancer Progressing on Chemotherapy
NSABP Foundation Inc
Phase 2 Completed
NCT04368507 2022-11-14
To Evaluate the Safety, Tolerability, Pharmacokinetics and Antitumor Activity of YYB101 With Irinotecan, Patients Who Are Metastatic or Recurrent Colorectal Cancer Patients
CellabMED
Phase 1/2 Completed
NCT01892527 2022-09-09
Study of Tivantinib (ARQ 197) Plus Cetuximab in EGFR Inhibitor-Resistant MET High Subjects
Istituto Clinico Humanitas
Phase 2 Completed
NCT01483027 2022-03-29
EPOCH
Boston Scientific Corporation
Phase NA Completed
NCT05273489 2022-03-10
Chemotherapy and Tumor Clearance in Hepatic Resections for Colorectal Liver Metastases.
Hospital Maciel
Completed
NCT03531632 2022-02-08
MGD007 Combined With MGA012 in Relapsed/Refractory Metastatic Colorectal Cancer
MacroGenics
Phase 1/2 Completed
NCT03556956 2020-12-08
Masitinib in Combination With FOLFIRI in Third or Fourth Line of Treatment of Patients With Metastatic Colorectal Cancer
AB Science
Phase 2/3 Completed
NCT03898102 2019-04-01
ZnCORRECT
Chang Gung Memorial Hospital
Phase 2 Completed
NCT02751177 2018-08-09
ColoBEAM
Institut de Cancérologie de Lorraine
Phase NA Completed
NCT01571284 2018-04-17
Safety and Quality of Life Study of Aflibercept in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin-Based Regimen
Sanofi
Phase 3 Completed
NCT02135757 2018-03-30
Study to Evaluate Real-world Pharmacoeconomics and Resistance Mechanisms of Panitumumab in Metastatic Colorectal Cancer Patients
PeriPharm
Completed
NCT02139215 2018-03-30
Study to Evaluate Real-world Pharmacoeconomics of Panitumumab in Metastatic Colorectal Cancer Patients
PeriPharm
Completed
NCT01882868 2017-03-14
A Study of Aflibercept in Combination With FOLFIRI in Patients With Second-Line Metastatic Colorectal Cancer in Japan
Sanofi
Phase 2 Completed
NCT02350400 2017-02-14
Pilot Study to Assess the Safety and Pharmacokinetics of 70-150μm Drug Eluting Beads Loaded With Irinotecan (DEBIRI).
Singapore General Hospital
Phase 1 Completed
NCT01670721 2016-11-28
AFEQT
Sanofi
Phase 3 Completed
NCT01661270 2016-10-18
AFLAME
Sanofi
Phase 3 Completed
NCT01909830 2015-06-19
Gemcitabine in Combination With Pemetrexed Long Term Infusion in the Treatment of Pretreated Metastatic Colorectal Cancer Patients
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Phase 2 Completed
NCT01163396 2015-03-11
FOIB
Gruppo Oncologico del Nord-Ovest
Phase 2 Completed